Kiromic BioPharma, Inc.
KRBPQ
$0.0615
-$0.083-57.44%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 1.14M | 2.92M | 4.05M | 3.68M | 3.20M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 1.51M | 1.25M | 1.85M | 1.89M | 1.23M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 658.00K | 132.00K | 131.00K | -- | -- |
| Total Current Assets | 3.30M | 4.30M | 6.03M | 5.57M | 4.43M |
|
|
|||||
| Total Current Assets | 3.30M | 4.30M | 6.03M | 5.57M | 4.43M |
| Net Property, Plant & Equipment | 5.22M | 5.92M | 6.42M | 7.04M | 7.72M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 21.00K | 21.00K | 21.00K | 21.00K | 21.00K |
| Total Assets | 8.55M | 10.25M | 12.46M | 12.63M | 12.17M |
|
|
|||||
| Total Accounts Payable | 2.68M | 1.69M | 2.00M | 2.00M | 2.14M |
| Total Accrued Expenses | 3.89M | 3.00M | 2.27M | 4.26M | 3.16M |
| Short-term Debt | 13.66M | 13.64M | 12.14M | 12.19M | 14.00M |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 685.00K | 670.00K | 656.00K | 642.00K | 631.00K |
| Total Finance Division Other Current Liabilities | -- | 130.00K | -- | -- | 448.00K |
| Total Other Current Liabilities | -- | 130.00K | -- | -- | 448.00K |
| Total Current Liabilities | 20.90M | 19.13M | 17.06M | 19.09M | 20.38M |
|
|
|||||
| Total Current Liabilities | 20.90M | 19.13M | 17.06M | 19.09M | 20.38M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | 13.66M | 13.64M | 12.14M | 12.19M | 14.00M |
| Capital Leases | 228.00K | 404.00K | 577.00K | 747.00K | 912.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 21.13M | 19.53M | 17.63M | 19.84M | 21.29M |
|
|
|||||
| Common Stock & APIC | 137.21M | 134.02M | 130.70M | 121.83M | 113.78M |
| Retained Earnings | -149.80M | -143.30M | -135.87M | -129.05M | -122.90M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | -12.59M | -9.29M | -5.17M | -7.21M | -9.12M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | 0.00 |
|
|
|||||
| Total Common Equity | -12.59M | -9.29M | -5.17M | -7.21M | -9.12M |
| Total Preferred Equity | -- | -- | -- | -- | 0.00 |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -12.59M | -9.29M | -5.17M | -7.21M | -9.12M |
|
|
|||||